top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Arteriogenesis and Therapeutic Neovascularization
Arteriogenesis and Therapeutic Neovascularization
Autore Deindl Elisabeth
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (220 p.)
Soggetto topico Medicine
Soggetto non controllato factor VII activating protease
HABP2
VEGF
matrigel
neo-vascularization
hind limb ischemia
angiogenesis
arteriogenesis
ERK
endothelial cells
inflammation
macrophages
atherosclerosis
pericyte
rAAV
capillary
microRNA
isomiRs
epitranscriptome
neovascularization
A-to-I editing
m6A
RNA modifications
RNA methylation
lower extremity arterial disease
peripheral arterial disease
blood flow restriction
activity-based benefits
training effects
effect mechanism
hyperoxygenation
vein graft disease
vascular biology
spinal cord ischemia
paraplegia
aortic disease
TAAA
collateral network
paraspinous compartment
NO
NOTCH
innate immunity
mast cell
GH and eNOS
IGF-I
oxidative stress and arterial inflammation
vascular homeostasis
GHAS trial
collateral artery growth
SMC proliferation
potassium channel
KV1.3
KCa3.1
FGFR-1
Egr-1
PDFG-R
αSM-actin
TLR2/6
femoral artery ligation
blood flow recovery
collateral growth
VHL loss of function
microRNA-212/132
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557495503321
Deindl Elisabeth  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Novel Biomarkers for Heart Disease
Novel Biomarkers for Heart Disease
Autore Lichtenauer Michael
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (420 p.)
Soggetto topico Medicine
Soggetto non controllato diet quality
ceramides
obesity
cardiovascular risk
healthy eating index
carbohydrate antigen-125
heart failure
inflammatory marker
older women
biomarker
cardiometabolic disease
epicardial adipose tissue
epicardial fat
epicardial fat volume
microRNA
thyroid-stimulating hormone
cardiometabolic risks
metabolic syndrome
hypertension
very low-density lipoprotein
STIM1
SOCE
atrial myopathy
atrial fibrillation
ejection fraction
soluble urokinase-type plasminogen activator receptor (suPAR)
growth differentiation factor 15 (GDF-15)
heart-type fatty acid-binding protein (H-FABP)
soluble suppression of tumorigenicity 2 (sST2)
acute myocardial infarction
biomarkers
catestatin
coronary artery disease
heart failure decompensation
left ventricular ejection fraction
troponin
NT-proBNP
NYHA functional class
GDF-15
cardiovascular surgery
operative risk
muscle wasting
sarcopenia
renal dysfunction
chronic kidney disease
aortic disease
aneurysm
miRNA
TGF-β pathway
KLF4
synthetic phenotype
aortic regurgitation
echocardiography
magnetic resonance imaging
vena contracta area
longitudinal strain
T1 mapping
GDF8
myostatin
AMI
ceruloplasmin
H-FABP
heart-type fatty acid-binding protein
FABP3
fatty acid-binding protein 3
HF
cardiac biomarkers
cardiac magnetic resonance imaging
left ventricular systolic function
magnetic resonance spectroscopy
myocardial triglyceride content
cell adhesion molecule
repeated measurements
pregnancy-associated plasma protein-A
cohort studies
cardiovascular diseases
mitochondrial dysfunction
circulating cells
PBMCS
platelets
oxidative stress
reactive oxygen species (ROS)
mitochondrial DNA (mtDNA)
herat failure
liver-type fatty-acid-binding protein
long-term outcomes
cardiac intensive care units
acute kidney injury
myocardial infarction
STEMI
cardiovascular events
cardiovascular death
risk stratification
sST2
Pentraxin-3
sudden cardiac death
ventricular arrhythmia
ventricular tachycardia
chronic heart failure
saliva
salivary biomarkers
CKD
CVD
PPCI
left ventricular adverse remodelling
circulating miRNAs
NAFLD
Framingham risk score
risk prediction
secondary prevention
primary prevention
NAFLD fibrosis score
HFpEF
HFrEF
suPAR
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557546203321
Lichtenauer Michael  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui